PIGT-CDG, a disorder of the glycosylphosphatidylinositol anchor: description of 13 novel patients and expansion of the clinical characteristics.


Journal

Genetics in medicine : official journal of the American College of Medical Genetics
ISSN: 1530-0366
Titre abrégé: Genet Med
Pays: United States
ID NLM: 9815831

Informations de publication

Date de publication:
10 2019
Historique:
received: 27 11 2018
accepted: 25 03 2019
pubmed: 13 4 2019
medline: 18 3 2020
entrez: 13 4 2019
Statut: ppublish

Résumé

To provide a detailed electroclinical description and expand the phenotype of PIGT-CDG, to perform genotype-phenotype correlation, and to investigate the onset and severity of the epilepsy associated with the different genetic subtypes of this rare disorder. Furthermore, to use computer-assisted facial gestalt analysis in PIGT-CDG and to the compare findings with other glycosylphosphatidylinositol (GPI) anchor deficiencies. We evaluated 13 children from eight unrelated families with homozygous or compound heterozygous pathogenic variants in PIGT. All patients had hypotonia, severe developmental delay, and epilepsy. Epilepsy onset ranged from first day of life to two years of age. Severity of the seizure disorder varied from treatable seizures to severe neonatal onset epileptic encephalopathies. The facial gestalt of patients resembled that of previously published PIGT patients as they were closest to the center of the PIGT cluster in the clinical face phenotype space and were distinguishable from other gene-specific phenotypes. We expand our knowledge of PIGT. Our cases reaffirm that the use of genetic testing is essential for diagnosis in this group of disorders. Finally, we show that computer-assisted facial gestalt analysis accurately assigned PIGT cases to the multiple congenital anomalies-hypotonia-seizures syndrome phenotypic series advocating the additional use of next-generation phenotyping technology.

Identifiants

pubmed: 30976099
doi: 10.1038/s41436-019-0512-3
pii: S1098-3600(21)04511-1
doi:

Substances chimiques

Glycosylphosphatidylinositols 0
Acyltransferases EC 2.3.-
COOH-terminal signal transamidase EC 2.3.2.-

Types de publication

Case Reports Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

2216-2223

Subventions

Organisme : Medical Research Council
ID : MR/N008324/1
Pays : United Kingdom
Organisme : Department of Health
Pays : United Kingdom
Organisme : Wellcome Trust
ID : WT098051
Pays : United Kingdom

Auteurs

Allan Bayat (A)

Department of Pediatrics, University Hospital of Hvidovre, Hvidovre, Denmark. allan.bayat@regionh.dk.
Danish Epilepsy Centre, Dianalund, Denmark. allan.bayat@regionh.dk.

Alexej Knaus (A)

Institute for Genomic Statistics and Bioinformatics, University Hospital Bonn, Bonn, Germany.

Annika Wollenberg Juul (AW)

Department of Pediatrics, University Hospital of Hvidovre, Hvidovre, Denmark.

Dejan Dukic (D)

Institute for Genomic Statistics and Bioinformatics, University Hospital Bonn, Bonn, Germany.

Elena Gardella (E)

Danish Epilepsy Centre, Dianalund, Denmark.
Institute for Regional Health Services Research, University of Southern Denmark, Odense, Denmark.

Agnieszka Charzewska (A)

Institute of Mother and Child, Department of Medical Genetics, Warsaw, Poland.

Emma Clement (E)

North East Thames Regional Genetics Service, Great Ormond Street Hospital for Children, London, UK.

Helle Hjalgrim (H)

Danish Epilepsy Centre, Dianalund, Denmark.
Institute for Regional Health Services Research, University of Southern Denmark, Odense, Denmark.
Amplexa Genetics, Odense, Denmark.

Dorota Hoffman-Zacharska (D)

Institute of Mother and Child, Department of Medical Genetics, Warsaw, Poland.

Denise Horn (D)

Institute for Medical Genetics and Human Genetics, Charité Universitätsmedizin Berlin, Berlin, Germany.

Rachel Horton (R)

Wessex Clinical Genetics Service and Division of Human Genetics, Princess Anne Hospital, Southampton, UK.

Jane A Hurst (JA)

North East Thames Regional Genetics Service, Great Ormond Street Hospital for Children, London, UK.

Dragana Josifova (D)

Guy's and St. Thomas NHS Trust, Clinical Genetics Department, Great Maze Pond, London, UK.

Line H G Larsen (LHG)

Amplexa Genetics, Odense, Denmark.

Karine Lascelles (K)

Department of Neuroscience, Evelina London Children's Hospital, St Thomas' Hospital, London, UK.

Ewa Obersztyn (E)

Institute of Mother and Child, Department of Medical Genetics, Warsaw, Poland.

Alistair Pagnamenta (A)

National Institute for Health Research Oxford Biomedical Research Centre, Wellcome Centre for Human Genetics, University of Oxford, Oxford, UK.

Deb K Pal (DK)

Department of Basic and Clinical Neuroscience, Institute of Psychiatry, Psychology and Neuroscience, King's College London, London, UK.

Manuela Pendziwiat (M)

Department of Neuropediatrics University Medical Center Schleswig-Holstein Christian Albrechts University Kiel, Kiel, Germany.

Mina Ryten (M)

Guy's and St. Thomas NHS Trust, Clinical Genetics Department, Great Maze Pond, London, UK.
Reta Lila Weston Research Laboratories, Department of Molecular Neuroscience, University College London, Institute of Neurology, London, UK.

Jenny Taylor (J)

National Institute for Health Research Oxford Biomedical Research Centre, Wellcome Centre for Human Genetics, University of Oxford, Oxford, UK.

Julie Vogt (J)

Clinical Genetics Unit, Birmingham Women's Hospital, Birmingham, UK.

Yvonne Weber (Y)

Department of Neurology and Epileptology, Hertie Institute of Clinical Brain Research, University of Tübingen, Tübingen, Germany.

Peter M Krawitz (PM)

Danish Epilepsy Centre, Dianalund, Denmark.

Ingo Helbig (I)

Department of Neuropediatrics University Medical Center Schleswig-Holstein Christian Albrechts University Kiel, Kiel, Germany.
Division of Neurology, The Children's Hospital of Philadelphia, Philadelphia, PA, USA.

Usha Kini (U)

Oxford Centre for Genomic Medicine Oxford University Hospitals NHS Trust, Oxford, UK.

Rikke S Møller (RS)

Danish Epilepsy Centre, Dianalund, Denmark. rimo@filadelfia.dk.
Institute for Regional Health Services Research, University of Southern Denmark, Odense, Denmark. rimo@filadelfia.dk.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH